These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Adams EW; Ratner DM; Seeberger PH; Hacohen N Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095 [TBL] [Abstract][Full Text] [Related]
27. Genetic and therapeutic control of diabetogenic CD8+ T cells. Santamaria P Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463 [TBL] [Abstract][Full Text] [Related]
28. Acquired pMHC I complexes greatly enhance CD4(+) Th cell's stimulatory effect on CD8(+) T cell-mediated diabetes in transgenic RIP-mOVA mice. Ahmed KA; Xie Y; Zhang X; Xiang J Cell Mol Immunol; 2008 Dec; 5(6):407-15. PubMed ID: 19118506 [TBL] [Abstract][Full Text] [Related]
34. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses. Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977 [TBL] [Abstract][Full Text] [Related]
35. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Gurer C; Strowig T; Brilot F; Pack M; Trumpfheller C; Arrey F; Park CG; Steinman RM; Münz C Blood; 2008 Aug; 112(4):1231-9. PubMed ID: 18519810 [TBL] [Abstract][Full Text] [Related]
36. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058 [TBL] [Abstract][Full Text] [Related]
37. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. Chaparro RJ; Burton AR; Serreze DV; Vignali DA; DiLorenzo TP J Immunol Methods; 2008 Jun; 335(1-2):106-15. PubMed ID: 18439618 [TBL] [Abstract][Full Text] [Related]
38. Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes. Trivedi P; Graham KL; Krishnamurthy B; Fynch S; Slattery RM; Kay TW; Thomas HE Immunol Cell Biol; 2016 Apr; 94(4):334-41. PubMed ID: 26446877 [TBL] [Abstract][Full Text] [Related]
39. The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells. Wang B; Kuroiwa JM; He LZ; Charalambous A; Keler T; Steinman RM Ann N Y Acad Sci; 2009 Sep; 1174():6-17. PubMed ID: 19769731 [TBL] [Abstract][Full Text] [Related]
40. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A. Joffre OP; Sancho D; Zelenay S; Keller AM; Reis e Sousa C Eur J Immunol; 2010 May; 40(5):1255-65. PubMed ID: 20333625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]